NAVIGEN INC has a total of 16 patent applications. It decreased the IP activity by 33.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are KHANMI SAJENS KO LTD, NICOLAU YVES CLAUDE and HANMI HOLDINGS CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | China | 2 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Environmental technology | |
#5 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Bajji Ashok | 8 |
#2 | Ostanin Kirill | 8 |
#3 | Kay Michael S | 7 |
#4 | Welch Brett D | 7 |
#5 | Mueller Alan | 5 |
#6 | Francis James Nicholas | 5 |
#7 | Papac Damon | 5 |
#8 | Vankayalapati Hariprasad | 3 |
#9 | Moss Neil | 3 |
#10 | Shenderovich Mark | 3 |
Publication | Filing date | Title |
---|---|---|
KR20200134203A | ARF6 inhibitors and related methods | |
EP3399994A1 | D-peptide inhibitors of hiv entry and methods of use | |
WO2017040350A1 | Compositions and methods related to inhibition of respiratory syncytial virus entry | |
EP3148986A1 | Arf6 inhibitors and methods of synthesis and use thereof |